Compare Pfizer Inc (PFE) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pfizer Inc vs Pinterest Inc — how do they compare? Pfizer Inc trades at $27.77 (market cap $158.56B), while Pinterest Inc trades at $20.57 (market cap $11.63B). The key difference: Pfizer Inc is far larger — about 13.6× Pinterest Inc's market cap, and Pfizer Inc pays a 6.18% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and Pinterest Inc for 85 Days on average.
| PFE | PINS | |
|---|---|---|
Market Cap | $158.56B | $11.63B |
Volume | 44,138,282 | 12,792,940 |
Sector | Health | Media |
52-Week High | $29.02 | $35.24 |
52-Week Low | $23.67 | $15.42 |
Typical Hold Time | 158 Days | 85 Days |
Enterprise Value | $210.06B | $11.55B |
Dividend Yield | 6.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $27.82, up 1.22% with a bullish technical signal from moving averages. The company shows stable revenue around $62-63B with consistent earnings beats in recent quarters. Analysts maintain a $29.40 consensus target with 40% buy ratings. Recent news highlights Pfizer's focus on obesity and oncology pipelines as key growth drivers.
Pfizer offers value with defensive cash flows and dividend stability, though patent cliffs and margin compression present challenges. The stock's current valuation appears reasonable relative to sector peers, with upside potential if pipeline developments succeed. Key risks include competitive pressures and regulatory hurdles for new drug approvals.
Pinterest (PINS) trades at $20.31, up 1.4% with a bullish technical signal despite mixed moving averages. The company shows strong revenue growth from $2.8B in 2022 to $4.2B in 2025, with recent earnings beats and robust 79.5% gross margins. Analysts maintain a Buy consensus with a $27.93 target, representing 37% upside potential from current levels.
PINS offers compelling growth prospects with expanding international monetization and new visual search advertising products. However, elevated valuation multiples (P/E 59.7) and negative cash flow trends present risks. Insider selling and competitive pressure in digital advertising require monitoring for sustained shareholder value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
